Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world and its prevalence is rising. In the absence of disease progression, fatty liver poses minimal risk of detrimental health outcomes. However, advancement to non-alcoholic steatohepatitis (NASH) confers a markedly...

Descripción completa

Detalles Bibliográficos
Autores principales: Riordan, Jesse D., Nadeau, Joseph H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164843/
https://www.ncbi.nlm.nih.gov/pubmed/24802098
http://dx.doi.org/10.1007/s00335-014-9521-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164843/
https://www.ncbi.nlm.nih.gov/pubmed/24802098
http://dx.doi.org/10.1007/s00335-014-9521-3

Ejemplares similares